Home DNA Damage/DNA Repair Antineoplastic and Immunosuppressive Antibiotics inhibitor - DNA/RNA Synthesis inhibitor Metronidazole For research use only.

Metronidazole

Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa.

Metronidazole Chemical Structure

Metronidazole Chemical Structure

CAS: 443-48-1

Selleck's Metronidazole has been cited by 3 publications

Purity & Quality Control

Batch: Purity: 99.97%
99.97

Related compound libraries

Choose Selective Antineoplastic and Immunosuppressive Antibiotics Inhibitors

Biological Activity

Description Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa.
Targets
DNA synthesis [1]
In vitro
In vitro Metronidazole is relatively inactive until it is metabolized within host or microbial cells. Metronidazole is activated when it receives an electron from ferredoxin or fla vodoxin that is reduced by POR in anaerobic or microaerophilic bacteria or luminal parasites. Metronidazole damages cells by forming protein and DNA adducts. [1] Metronidazole has activity against protozoans like Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis, for which the drug is first approved as an effective treatment. The activity of metronidazole against anaerobic bowel flora has been used for prophylaxis and treatment of patients with Crohn's disease who might develop an infectious complication. Metronidazole has played an important role in anaerobic-related infections.   Metronidazole has notable effectiveness in treating anaerobic brain abscesses. [2] Metronidazole resistance tends to result from de novo mutation in the resident rdxA gene, rather than from lateral transfer of mutant rdxA (or other) genes from unrelated but Mtzr strains. Metronidazole partially inhibits growth stimulate forward mutation to rifampin resistance in rdxA(+) (Metronidazole(s)) and also in rdxA (Metronidazole(r)) H. pylori strains, and that expression of rdxA in Escherichia coli results in equivalent Mtz-induced mutation. [3] Metronidazole leads to apoptosis-like features in growing cultures of axenic B. hominis, including key morphological and biochemical features of programmed cell death (PCD), viz. nuclear condensation and nicked DNA in nucleus, reduced cytoplasmic volume, externalization of phosphatidylserine and maintenance of plasma membrane integrity with increasing permeability. [4]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05748145 Recruiting Colorectal Cancer Oncology Institute of Southern Switzerland September 11 2023 Phase 2
NCT04273997 Unknown status Pilonidal Sinus S.L.A. Pharma AG October 1 2021 Phase 2
NCT04979832 Recruiting Pouchitis Zealand University Hospital September 6 2021 Phase 1|Phase 2

Chemical lnformation & Solubility

Molecular Weight 171.15 Formula

C6H9N3O3
CAS No. 443-48-1 SDF Download Metronidazole SDF
Smiles CC1=NC=C(N1CCO)[N+](=O)[O-]
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 34 mg/mL ( (198.65 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Metronidazole | Metronidazole ic50 | Metronidazole price | Metronidazole cost | Metronidazole solubility dmso | Metronidazole purchase | Metronidazole manufacturer | Metronidazole research buy | Metronidazole order | Metronidazole mouse | Metronidazole chemical structure | Metronidazole mw | Metronidazole molecular weight | Metronidazole datasheet | Metronidazole supplier | Metronidazole in vitro | Metronidazole cell line | Metronidazole concentration | Metronidazole nmr